Patent Assignment
Reel/Frame 072771/0247
Change of Address
Recorded: 2025-08-29
Pages: 2
Assignor
XERIS PHARMACEUTICALS, INC.
Executed: 2025-08-29
Assignee
XERIS PHARMACEUTICALS, INC.
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, ILLINOIS, 60607
Covered Property
(1)
Methods for Treating Congenital Hyperinsulinism
Application:
16/630,774 →
Publication:
US 2020/0147306
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Intellectual Property Security Agreement
May 4, 2021
From: XERIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 056135/0800 →
Security Interest
Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
Reassignment and Release of Security Interest
Mar 10, 2022
From: OXFORD FINANCE LLC
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 059358/0714 →
Assignment of Assignor's Interest
Aug 19, 2025
From: PRESTRELSKI, STEVEN J.; KINZELL, JOHN; NEWSWANGER, BRETT; THORNTON, PAUL
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 072061/0127 →